New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…